Cellectis Company Insiders
CLLS Stock | USD 1.87 0.01 0.54% |
Cellectis employs about 216 people. The company is managed by 12 executives with a total tenure of roughly 55 years, averaging almost 4.0 years of service per executive, having 18.0 employees per reported executive. Breaking down Cellectis' management performance can provide insight into the firm performance.
Andre Choulika Chairman Chairman of the Board and CEO, Member of the Executive Committee |
Cellectis |
Cellectis Management Team Effectiveness
The company has return on total asset (ROA) of (0.1609) % which means that it has lost $0.1609 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.822) %, meaning that it created substantial loss on money invested by shareholders. Cellectis' management efficiency ratios could be used to measure how well Cellectis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.32 in 2024. Return On Capital Employed is likely to drop to -0.57 in 2024. At this time, Cellectis' Other Current Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 243.1 M in 2024, whereas Total Assets are likely to drop slightly above 270.8 M in 2024.Common Stock Shares Outstanding is likely to drop to about 33.4 M in 2024. Net Loss is likely to drop to about (100.3 M) in 2024
Cellectis Workforce Comparison
Cellectis SA is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2,725. Cellectis holds roughly 216 in number of employees claiming about 8% of equities under Health Care industry.
Cellectis Profit Margins
The company has Profit Margin (PM) of (2.34) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.0226 | 0.0238 |
|
|
Cellectis SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cellectis SA Price Series Summation is a cross summation of Cellectis price series and its benchmark/peer.
Cellectis Notable Stakeholders
A Cellectis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cellectis often face trade-offs trying to please all of them. Cellectis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cellectis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Andre Choulika | Chairman of the Board and CEO, Member of the Executive Committee | Profile | |
David Sourdive | Co-Founder, Executive VP of Corporate Devel. and Director | Profile | |
MarieBleuenn Terrier | General Counsel, Member of the Executive Committee | Profile | |
Dr MBA | Chief Officer | Profile | |
Valerie Cros | Principal Officer | Profile | |
Kyung NamWortman | Executive Officer | Profile | |
Philippe Duchateau | Chief Scientific Officer | Profile | |
Pascalyne Wilson | Director Communications | Profile | |
Stephan MSc | Chief Officer | Profile | |
Jean Epinat | Chief Officer | Profile | |
MSc MSc | Chief Officer | Profile | |
Arthur Stril | Interim Officer | Profile |
About Cellectis Management Performance
The success or failure of an entity such as Cellectis SA often depends on how effective the management is. Cellectis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cellectis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cellectis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.30) | (0.32) | |
Return On Capital Employed | (0.54) | (0.57) | |
Return On Assets | (0.30) | (0.32) | |
Return On Equity | (1.19) | (1.25) |
Please note, the imprecision that can be found in Cellectis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cellectis SA. Check Cellectis' Beneish M Score to see the likelihood of Cellectis' management manipulating its earnings.
Cellectis Workforce Analysis
Traditionally, organizations such as Cellectis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cellectis within its industry.Cellectis Manpower Efficiency
Return on Cellectis Manpower
Revenue Per Employee | 3.5K | |
Revenue Per Executive | 62.9K | |
Net Loss Per Employee | 540.9K | |
Net Loss Per Executive | 9.7M | |
Working Capital Per Employee | 360.5K | |
Working Capital Per Executive | 6.5M |
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.